CoChat

Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study

Muehlbacher, Moritz, Nickel, Marius K., Nickel, Cerstin, Kettler, Christian, Lahmann, Claas, Gil, Francisco Pedrosa, Leiberich, Peter K., Rother, Nadine, Bachler, Egon, Fartacek, Reinhold, Kaplan, Patrick, Tritt, Karin, Mitterlehner, Ferdinand, Anvar, Javaid, Rother, Wolfhardt K., Loew, Thomas H., Egger, Christoph · 2005 · Journal of Clinical Psychopharmacology
Cited by 79

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Social phobia is an anxiety disorder characterized by extreme fear and phobic avoidance of social and performance situations and by a relatively poor health-related quality of life. The goal of this study was to compare the efficacy of mirtazapine versus placebo in the treatment of patients with social phobia. In 2004, we conducted a randomized, double-blind, placebo-controlled study of mirtazapine in 66 female subjects from the general population meeting the criteria for social phobia. The subjects were randomly assigned in a 1:1 manner to mirtazapine (n = 33) or placebo (n = 33). The treatment lasted 10 weeks. Seven patients dropped out. Primary outcome measures were self-reported changes on the Social Phobia Inventory, Liebowitz Social Anxiety Scale, and Health Survey (SF-36). In comparison with the placebo group and according to the intent-to-treat principle, significant differences on the Social Phobia Inventory and Liebowitz Social Anxiety Scale scales (all P < 0.001), as well as on most (5 from 8) scales of SF-36 (all P < 0.001), were observed in the mirtazapine-treated subjects. All patients tolerated mirtazapine relatively well. Mirtazapine appears to be an effective agent in the treatment of social phobia in women and in the improvement of their health-related quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jcp.0000186871.04984.8d

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 16

  1. Antony, 1997, Can J Psychiatry, 42, 826, 10.1177/070674379704200804 · DOI · Paper page
  2. Kessler, 1994, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  3. Wttchen, 1999, Eur Psychiatry, 14, 118, 10.1016/S0924-9338(99)80729-9 · DOI · Paper page
  4. Tillfors, 2002, Biol Psychiatry, 52, 1113, 10.1016/S0006-3223(02)01396-3 · DOI · Paper page
  5. Liebowitz, 2003, J Clin Psychiatry, 64, 785, 10.4088/JCP.v64n0708 · DOI · Paper page
  6. Stein, 1999, Am J Psychiatry, 156, 756, 10.1176/ajp.156.5.756 · DOI · Paper page
  7. Goodnick, 1999, J Clin Psychiatry, 60, 446, 10.4088/JCP.v60n0705 · DOI · Paper page
  8. Van Veen, 2002, Int Clin Psychopharmacol, 17, 315, 10.1097/00004850-200211000-00008 · DOI · Paper page
  9. Liappas, 2003, J Affect Disord, 76, 279, 10.1016/S0165-0327(02)00094-0 · DOI
  10. Haapasalo-Pesu, 2004, J Child Adolesc Psychopharmacol, 14, 175, 10.1089/1044546041649110 · DOI
  11. Rickels, 2004, J Clin Psychopharmacol, 24, 488, 10.1097/01.jcp.0000138764.31106.60 · DOI · Paper page
  12. Kobak, 2005, J Clin Psychopharmacol, 25, 51, 10.1097/01.jcp.0000150227.61501.00 · DOI · Paper page
  13. Westenberg, 2004, J Clin Psychopharmacol, 24, 49, 10.1097/01.jcp.0000104906.75206.8b · DOI · Paper page
  14. Van Ameringen, 2004, J Clin Psychopharmacol, 24, 42, 10.1097/01.jcp.0000104909.75206.6f · DOI · Paper page
  15. Nickel, 2004, Wien Med Wochenschr, 154, 163, 10.1007/s10354-004-0058-z · doi:10.1007/s10354-004-0058-z
  16. Nickel, 2004, J Clin Psychiatry, 65, 1515, 10.4088/JCP.v65n1112 · DOI · Paper page

Cited by

See all 79

Metadata

Authors
Muehlbacher, M., Nickel, M. K., Nickel, C., Kettler, C., Lahmann, C., Gil, F. P., Leiberich, P. K., Rother, N., Bachler, E., Fartacek, R., Kaplan, P., Tritt, K., Mitterlehner, F., Anvar, J., Rother, W. K., Loew, T. H., & Egger, C.
Venue
Journal of Clinical Psychopharmacology
Published
2005-12
Volume
25
Issue
6
Pages
580-583
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1974450862
Cited by
79
References
3
FWCI
6.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.1097/01.jcp.0000186871.04984.8d
The paper
Muehlbacher, M., Nickel, M. K., Nickel, C., Kettler, C., Lahmann, C., Gil, F. P., Leiberich, P. K., Rother, N., Bachler, E., Fartacek, R., Kaplan, P., Tritt, K., Mitterlehner, F., Anvar, J., Rother, W. K., Loew, T. H., & Egger, C. (2005). Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000186871.04984.8d

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.